ASCENDIA PHARMACEUTICALS, INC. research brief
CIK 1855888
Generated Nov. 18, 2026, 4:58 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NORTH BRUNSWICK New Jersey. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Nov. 6, 2026 · D/A · 0001855888-26-000008 · Source evidence
Reported offering amount: 4084536 USD. Reported amount sold: 4084536 USD.
- July 24, 2026 · D · 0001855888-26-000005 · Source evidence
Reported offering amount: 4084536 USD. Reported amount sold: 4084536 USD.
- June 4, 2025 · D · 0001855888-25-000001 · Source evidence
Reported offering amount: 2500000 USD. Reported amount sold: 2500000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “ASCENDIA PHARMACEUTICALS, INC. research brief,” CIK 1855888, retrieved Nov. 18, 2026, 4:58 a.m.. Cite the specific accessions used. No amounts have been summed.